These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25316827)

  • 1. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria.
    Michael CA; Ashenafi S; Ogbuanu IU; Ohuabunwo C; Sule A; Corkum M; Mackay S; Storms AD; Achari P; Biya O; Nguku P; Newberry D; Bwaka A; Mahoney F;
    J Infect Dis; 2014 Nov; 210 Suppl 1():S131-5. PubMed ID: 25316827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward poliomyelitis eradication in Nigeria.
    Ado JM; Etsano A; Shuaib F; Damisa E; Mkanda P; Gasasira A; Banda R; Korir C; Johnson T; Dieng B; Corkum M; Enemaku O; Mataruse N; Ohuabunwo C; Baig S; Galway M; Seaman V; Wiesen E; Vertefeuille J; Ogbuanu IU; Armstrong G; Mahoney FJ
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S40-9. PubMed ID: 25316862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demand Creation for Polio Vaccine in Persistently Poor-Performing Communities of Northern Nigeria: 2013-2014.
    Warigon C; Mkanda P; Muhammed A; Etsano A; Korir C; Bawa S; Gali E; Nsubuga P; Erbeto TB; Gerlong G; Banda R; Yehualashet YG; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S79-85. PubMed ID: 26908717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polio elimination in Nigeria: A review.
    Nasir UN; Bandyopadhyay AS; Montagnani F; Akite JE; Mungu EB; Uche IV; Ismaila AM
    Hum Vaccin Immunother; 2016 Mar; 12(3):658-63. PubMed ID: 26383769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outreach to underserved communities in northern Nigeria, 2012-2013.
    Gidado SO; Ohuabunwo C; Nguku PM; Ogbuanu IU; Waziri NE; Biya O; Wiesen ES; Mba-Jonas A; Vertefeuille J; Oyemakinde A; Nwanyanwu O; Lawal N; Mahmud M; Nasidi A; Mahoney FJ;
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S118-24. PubMed ID: 25316825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.
    Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Banda R; Korir C; Enemaku O; Corkum M; Usman S; Davis LB; Nganda Gw; Burns CC; Mahoney F; Vertefeuille JF;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1059-63. PubMed ID: 25412063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of polio supplemental immunization activities in Kano, Katsina, and Zamfara States, Nigeria: lessons in progress.
    Gammino VM; Nuhu A; Gerber S; Gasasira A; Sugerman DE; Manneh F; Chenoweth P; Kurnit MR; Abanida EA
    J Infect Dis; 2014 Nov; 210 Suppl 1():S91-7. PubMed ID: 25316881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking community barriers to polio vaccination in Northern Nigeria: the impact of a grass roots mobilization campaign (Majigi).
    Nasiru SG; Aliyu GG; Gasasira A; Aliyu MH; Zubair M; Mandawari SU; Waziri H; Nasidi A; El-Kamary SS
    Pathog Glob Health; 2012 Jul; 106(3):166-71. PubMed ID: 23265374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revelation of an important weakness in polio elimination efforts in Nigeria: a descriptive cross-sectional study of nomadic dynamics in Sokoto and Taraba States, May 2013.
    Aliyu N; Bawa MK; Gidado S; Ohuabunwo C; Esapa L; Archer WR; Sule A; Bolatito HA; Mamman A; Olayinka A; Balogun MS; Getso KI; Dalhat MM; Haladu AS; Shehu UL; Nguku PM; Shehu A; Abdulganiyu S; Waziri NE
    Pan Afr Med J; 2021; 40(Suppl 1):12. PubMed ID: 36157561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.
    Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
    PLoS One; 2015; 10(6):e0130123. PubMed ID: 26068928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding vaccine hesitancy in polio eradication in northern Nigeria.
    Taylor S; Khan M; Muhammad A; Akpala O; van Strien M; Morry C; Feek W; Ogden E
    Vaccine; 2017 Nov; 35(47):6438-6443. PubMed ID: 29031691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of unmet needs to address noncompliant households during polio supplemental immunization activities in Kaduna state, 2014-2016.
    Iyal HA; Shuaib F; Dauda M; Suleiman A; Braka F; Tegegne SG; Nsubuga P; Nomhwange T; Yehualashet YG; Ishaku S; Warigon C; Zakari F; Umeh G; Samaila L; Abdullahi B; Hammanyero K; Dogo P; Adamu D; Vaz RG; Alemu W
    BMC Public Health; 2018 Dec; 18(Suppl 4):1309. PubMed ID: 30541500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences from polio supplementary immunization activities in Anambra State, Nigeria.
    Onyeka IN; Ilika AL; Ilika FN; Umeh DC; Onyibe RI; Okoye CJ; Diden G; Onubogu CU
    Niger J Clin Pract; 2014; 17(6):808-13. PubMed ID: 25385924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress toward poliomyelitis eradication - Nigeria, January 2011-September 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Nov; 61(44):899-904. PubMed ID: 23134973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polio field census and vaccination of underserved populations--northern Nigeria, 2012-2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):663-5. PubMed ID: 23965829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing transit polio vaccination in collaboration with targeted stakeholders in Kaduna State, Nigeria: Lessons learnt: 2014-2015.
    Musa A; Abba B; Ningi AM; Gali E; Bawa S; Manneh F; Mkanda P; Banda R; Yehuluashet YG; Tegegne SG; Umeh G; Nsubuga P; Etsano A; Shuaib F; Mohammed A; Vaz RG
    Vaccine; 2016 Oct; 34(43):5159-5163. PubMed ID: 27364095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward poliomyelitis eradication - Nigeria, January 2012-September 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Dec; 62(49):1009-13. PubMed ID: 24336134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
    Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
    J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transboundary nomadic population movement: a potential for import-export of poliovirus.
    Bawa S; Afolabi M; Abdelrahim K; Abba G; Ningi A; Tafida SY; Tegegne SG; Warigon C; Nomhwange T; Umar SA; Aregay A; Fanti A; Ahmed B; Nsubuga P; Adamu U; Braka F; Wondimagegnehu A; Shuaib F
    BMC Public Health; 2018 Dec; 18(Suppl 4):1316. PubMed ID: 30541502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.
    Musa A; Mkanda P; Manneh F; Korir C; Warigon C; Gali E; Banda R; Umeh G; Nsubuga P; Chevez A; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S91-5. PubMed ID: 26609003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.